Personalized Circulating Tumor DNA (ctDNA) Profiling Enables Superior and Universal Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML)
个性化循环肿瘤DNA(ctDNA)分析可实现急性髓系白血病(AML)中更优、更通用的可测量残留病灶(MRD)检测
期刊:Open Forum Infectious Diseases
影响因子:
doi:10.64898/2026.01.28.26344873
Gunaratne, Ruwan; Zhou, Crystal; Rajaram, Sanjeeth; Tai, Jesse W; Tanaka, Kailee; Tiwari, Charu; Yang, Emily; Kim, Sky; Gao, Grace; Yin, Raymond; Carleton, Mia; Alkaitis, Matthew S; Schwede, Matthew; Sworder, Brian J; Mannis, Gabriel N; Khodadoust, Michael S; Majeti, Ravindra; Kurtz, David M; Zhang, Tian Yi